Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020
- PMID: 33175722
- PMCID: PMC7670831
- DOI: 10.12659/MSM.926941
Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020
Abstract
BACKGROUND At present, the relationships among COVID-19 disease progression, patient prognosis, and immune status are unclear. This single-center retrospective study evaluated the correlation between serum interleukin-6 (IL-6) levels at admission with the severity of COVID-19 pneumonia, as determined by admission to the intensive Care Unit (ICU). MATERIAL AND METHODS Patients admitted to The First Affiliated Hospital of Bengbu Medical College in Bengbu City, Anhui Province, China, in January and February 2020 for COVID-19 pneumonia were enrolled in this study. COVID-19 infection was confirmed by the detection of SARS-CoV-2 nucleic acid in throat swab samples using real-time fluorescent reverse transcription PCR. Serum IL-6 concentrations at admission were measured by ELISA. Correlations between serum IL-6 concentrations and ICU admission due to the development of severe COVID-19 pneumonia were evaluated. RESULTS This study enrolled 68 patients with novel coronavirus pneumonia. IL-6 concentrations were significantly higher in patients with more severe than less severe COVID-19 pneumonia. Eight of 40 patients with severe COVID-19 pneumonia became critically ill and required ICU admission. IL-6 concentrations were significantly higher in patients with severe COVID-19 pneumonia who were than who were not treated in the ICU. The area under the receiver operating characteristic (ROC) curve (AUC) was 0.816 (P<0.01), indicating that IL-6 was prognostic of disease severity in patients with COVID-19 pneumonia. CONCLUSIONS Serum IL-6 concentration is closely associated with the severity of COVID-19. Continuous monitoring of IL-6 has clinical value in evaluating patient condition.
Figures


Similar articles
-
Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.Clin Exp Med. 2023 Nov;23(7):3719-3728. doi: 10.1007/s10238-023-01114-0. Epub 2023 Jun 13. Clin Exp Med. 2023. PMID: 37310657 Free PMC article.
-
Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.Cytokine. 2021 Jan;137:155302. doi: 10.1016/j.cyto.2020.155302. Epub 2020 Sep 29. Cytokine. 2021. PMID: 33002740 Free PMC article.
-
Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.Clin Infect Dis. 2020 Nov 5;71(8):1937-1942. doi: 10.1093/cid/ciaa449. Clin Infect Dis. 2020. PMID: 32301997 Free PMC article.
-
Hematological Parameters Predict Disease Severity and Progression in Patients with COVID-19: a Review Article.Clin Lab. 2021 Jan 1;67(1). doi: 10.7754/Clin.Lab.2020.200655. Clin Lab. 2021. PMID: 33491422 Review.
-
COVID-19 and geriatric population: from pathophysiology to clinical perspectives.Horm Mol Biol Clin Investig. 2021 Feb 4;42(1):87-98. doi: 10.1515/hmbci-2020-0053. Horm Mol Biol Clin Investig. 2021. PMID: 33544506 Review.
Cited by
-
The Mediating Roles of Lung Function Traits and Inflammatory Factors on the Associations between Measures of Obesity and Risk of Lower Respiratory Tract Infections: A Mendelian Randomization Study.Healthcare (Basel). 2024 Sep 20;12(18):1882. doi: 10.3390/healthcare12181882. Healthcare (Basel). 2024. PMID: 39337223 Free PMC article.
-
Association of Renal Impairment with Interleukin-6 Levels on Clinical Outcomes among COVID-19 Patients in a Tertiary Government COVID-19 Referral Hospital.Acta Med Philipp. 2024 Feb 15;58(2):46-53. doi: 10.47895/amp.vi0.6661. eCollection 2024. Acta Med Philipp. 2024. PMID: 38966158 Free PMC article.
-
Association of Inflammatory Markers with COVID-19 Outcome among Hospitalized Patients: Experience from a Tertiary Healthcare Center in Western India.Maedica (Bucur). 2021 Dec;16(4):620-627. doi: 10.26574/maedica.2021.16.4.620. Maedica (Bucur). 2021. PMID: 35261664 Free PMC article.
-
Ct, IL-18 polymorphism, and laboratory biomarkers for predicting chemosensory dysfunctions and mortality in COVID-19.Future Sci OA. 2023 Mar 9;9(2):FSO838. doi: 10.2144/fsoa-2022-0082. eCollection 2023 Feb. Future Sci OA. 2023. PMID: 36999046 Free PMC article.
-
Non-Coding RNAs in COVID-19: Emerging Insights and Current Questions.Noncoding RNA. 2021 Aug 31;7(3):54. doi: 10.3390/ncrna7030054. Noncoding RNA. 2021. PMID: 34564316 Free PMC article. Review.
References
-
- Yang F, Shi S, Zhu J, et al. Clinical characteristics and outcomes of cancer patients with COVID-19. J Med Virol. 2020 [Online ahead of print] - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous